Drug-mediated inactivation of cytochrome P450. (Q41555359)

3 October 2017

1 reference

title

Drug-mediated inactivation of cytochrome P450. (English)

1 reference

3 October 2017

Murray M

1

1 reference

3 October 2017

publication date

1 July 1997

1 reference

Clinical and Experimental Pharmacology and Physiology

3 October 2017

published in

1 reference

3 October 2017

volume

24

1 reference

3 October 2017

issue

7

1 reference

3 October 2017

page(s)

465-470

1 reference

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Covalent bonding of the prosthetic heme to protein: a potential mechanism for the suicide inactivation or activation of hemoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Destruction of cytochrome P-450 by 2-isopropyl-4-pentenamide and methyl 2-isopropyl-4-pentenoate: Mass spectrometric characterization of prosthetic heme adducts and nonparticipation of epoxide metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Alkylation of the prosthetic heme in cytochrome P-450 during oxidative metabolism of the sedative-hypnotic ethchlorvynol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Oxidative metabolism of spironolactone: evidence for the involvement of electrophilic thiosteroid species in drug-mediated destruction of rat hepatic cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Isolation of two N-monosubstituted protoporphyrins, bearing either the whole drug or a methyl group on the pyrrole nitrogen atom, from liver of mice given griseofulvin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Interaction of aliphatic N-hydroxylamines with microsomal cytochrome P450: Nature of the different derived complexes and inhibitory effects on monoxygenases activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

A comparative NMR study between the macrolide antibiotic roxithromycin and erythromycin A with different biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Difference between single and multiple dose pharmacokinetics of orphenadrine hydrochloride in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Effects of erythromycin on hepatic drug-metabolizing enzymes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01228.X

Characterization of the inhibition of P4501A2 by furafylline

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Defective oxidation of drugs: pharmacokinetic and therapeutic implications

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

In vitro inhibition by stiripentol of rat brain cytochrome P-450-mediated naphthalene hydroxylation

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Selective reactivation of steroid hydroxylases following dissociation of the isosafrole metabolite complex with rat hepatic cytochrome P-450

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Pharmacokinetic drug interactions of macrolides

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Spectral interaction of orphenadrine and its metabolites with oxidized and reduced hepatic microsomal cytochrome P-450 in the rat

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Covalent modification of lysine during the suicide inactivation of rat liver cytochrome P-450 by chloramphenicol

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

A predictive model for substrates of cytochrome P450-debrisoquine (2D6)

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Reversal of the effects of isoniazid on hepatic cytochrome P-450 by potassium ferricyanide

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in humans

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

In vitro interaction of rat liver cytochromes P-450 with erythromycin, oleandomycin and erythralosamine derivatives. Importance of structural factors

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Irreversible binding of heme to microsomal protein during inactivation of cytochrome P450 by 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

The interactions of hydrazine derivatives with rat-hepatic cytochrome P-450

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Stiripentol kinetics in epilepsy: nonlinearity and interactions

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Possible interaction between cyclosporine and josamycin: a description of three cases

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.1997.TB01228.X

Identifiers

DOI

10.1111/J.1440-1681.1997.TB01228.X

1 reference

3 October 2017

1 reference